Nemaura Medical Inc. (NMRD)
Makes wearable devices that help diabetics track blood sugar levels continuously.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+0.0%
The outlook
NMRD trades near its 52-week lows, sitting well below both its 50- and 200-day moving averages. The stock sits about 18% of the way up from its yearly low, reflecting a prolonged downtrend. Current analyst coverage is thin, and the overall data lean is bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Market cap
$4,035
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—